Presentation is loading. Please wait.

Presentation is loading. Please wait.

11 Jo Anne Goodnight SBIR/STTR Program Coordinator Office of Extramural Research, NIH 301.435.2688 “Lab to Life” NIH SBIR/STTR Funding Opportu“NIH”tieS.

Similar presentations

Presentation on theme: "11 Jo Anne Goodnight SBIR/STTR Program Coordinator Office of Extramural Research, NIH 301.435.2688 “Lab to Life” NIH SBIR/STTR Funding Opportu“NIH”tieS."— Presentation transcript:

1 11 Jo Anne Goodnight SBIR/STTR Program Coordinator Office of Extramural Research, NIH 301.435.2688 “Lab to Life” NIH SBIR/STTR Funding Opportu“NIH”tieS National Institutes of Health Presentation to the Monte Jade Science & Technology Association October 22, 2008

2 22 Topics to Discuss Today SBIR/STTR Program Overview SBIR/STTR Program Overview NIH SBIR/STTR Program Specifics NIH SBIR/STTR Program Specifics Transitioning NIH SBIR/STTR Innovations to the Marketplace Transitioning NIH SBIR/STTR Innovations to the Marketplace Answer Your Questions! Answer Your Questions!

3 33 COMMON SOURCES CAPITAL TO JUMP-START YOUR START-UP Personal savings Credit cards Selling assets (boats & other toys) Second mortgages Loans & investments from family, friends and ….. Suppliers, vendors, other businesses Commercial bank loans Private investors, Angels Government Grants Venture Capital

4 44 The largest, most accessible source of SEED CAPITAL for the nation’s innovative small businesses $2.3 Billion in 2008 SBIR/STTR PROGRAMS

5 OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR …and This capital is in the form of grants and contracts no repayment no debt service no equity forfeiture no IP forfeiture

6 66 SBIR/STTR Program Overview SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM Set-aside program for small business concerns to engage in Federal R&D -- with potential for commercialization. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM Set-aside program to facilitate cooperative R&D between small businesses and research institutions -- with potential for commercialization. 2.5% 0.3% The best way to predict the future… is to create it.

7 77 SBIR Purpose and Goals Small Business Innovation Development Act of 1982 P.L. 106-554 (Signed 12/21/2000 extends program through 09/30/2008) Stimulate technological innovation Use small business to meet Federal R&D needs Foster and encourage participation by minorities and disadvantaged persons in technological innovation Increase private-sector commercialization innovations derived from Federal R&D “We in government must work in partnership with small businesses to ensure that technologies and processes are readily transferred to commercial applications.” – Ronald Reagan, July 22, 1982. SBIR/STTR Program Overview

8 88 STTR Purpose and Goals Small Business Research and Development Enhancement Act of 1992 P.L. 107-50 (Program reauthorized through 09/30/2009) Stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions Foster technology transfer between small business concerns and research institutions SBIR/STTR Program Overview

9 99 PHASE II  Full Research/R&D  $750K and 2-year Award (SBIR & STTR)  Pre-requisite: Phase I award PHASE III  Commercialization Stage  Must use non-SBIR/STTR Funds PHASE I  Feasibility Study  $100K and 6- month (SBIR) or 12- month (STTR) Award SBIR/STTR: 3-Phase Program SBIR/STTR Program Overview

10 10 SBIR/STTR ELIGIBILITY CRITERIA U.S. small business organized for-profit At least 51% U.S.- owned by individuals and independently operated or At least 51% owned and controlled by another (one) business concern that is at least 51% owned and controlled by one or more individuals 500 or fewer employees, including affiliates PI primarily employed with the small business STTR: Formal collaboration between small business and research institution SBIR/STTR Program Overview

11 11 Topics to Discuss Today SBIR/STTR Program Overview SBIR/STTR Program Overview NIH SBIR/STTR Program Specifics NIH SBIR/STTR Program Specifics Transitioning NIH SBIR/STTR Innovations to the Marketplace Transitioning NIH SBIR/STTR Innovations to the Marketplace

12 12 Improve human health through prevention, detection, diagnosis and treatment of disease or disability Speed process of discovery Reduce cost of medical care Improve research tools/ reduce cost of research Increase health knowledge base SBIR/STTR Programs Are Fully Integrated Within NIH Research Agenda Bridging the Discovery to Development Gap

13 SBIR STTR. N/A Set-aside % Growth of the SBIR/STTR Budget Over 25 Years NIH SBIR/STTR Program Specifics

14 14 Office of the Director National Center on Minority Health and Health Disparities Organizational Structure of NIH National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases National Cancer Institute National Institute on Aging National Institute of Child Health and Human Development National Institute of Allergy and Infectious Diseases National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Dental and Craniofacial Research National Institute on Drug Abuse National Institute of Environmental Health Sciences National Institute on Deafness and Other Communication Disorders National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of General Medical Sciences National Institute of Nursing Research National Library of Medicine National Center for Complementary and Alternative Medicine Fogarty International Center National Center for Research Resources National Institute of Biomedical Imaging and Bioengineering No funding authority

15 15 NIH INSTITUTE/CENTER SBIR/STTR BUDGET ALLOCATIONS (FY2008) Extramural R&D Set-Asides: SBIR = 2.5% STTR = 0.3% FY 2008 SBIR/STTR Budget Allocations to NIH ICs: $580 M (SBIR) $ 70 M (STTR) Total: $650 M NIDDK NIGMS

16 16 NIH SBIR Funding in FY2007 – Top 10 Awards and Dollars StateAwardsAmount Awarded CALIFORNIA263103,862,962 MASSACHUSETTS20674,503,651 MARYLAND10134,907,762 NEW YORK8331,156,040 PENNSYLVANIA7429,030,771 TEXAS7926,814,616 OHIO5319,964,206 OREGON4819,894,707 WASHINGTON5418,739,713 WISCONSIN4615,811,543 NIH SBIR/STTR Program Specifics

17 17 Number Of NIH Competing SBIR Applications FY 1995 - 2007 Phase 1 = All R43 and U43; Phase 2 = Other competing R44 and U44 -15% -12% -21% NIH SBIR/STTR Program Specifics

18 18 Success Rates of Competing SBIR Applications NIH SBIR/STTR Program Specifics

19 19 PHASE II (Full Research/R&D)  Average $850K and 2-years; can be longer PHASE II + (Competing Renewal/R&D)  Clinical R&D; Complex Instrumentation/Tools  Many, but not all, ICs participate  $1M/year; 3 years PHASE III (Commercialization Stage)  NIH, generally, not the “customer”  Consider exit strategy early PHASE I (Feasibility Study )  Average award: $170K  Project Period: Varies. Most awards on a 1-yr NCE NIH SBIR/STTR: 3-Phase Program

20 20 NIH, CDC & FDA SBIR/STTR Grant Solicitation “Parent FOAs” Release: January Standard Due Dates: April 5, Aug 5, Dec 5 (AIDS/AIDS-related: May 7, Sept 7, Jan 7) SBIR Contract Solicitation (NIH, CDC) Release: AugustNovember receipt date NIH Guide for Grants and Contracts Release: WeeklyReceipt dates specified in each FOA Solicitations and Due Dates SBIR: PA-08-050 STTR: PA-08-051PA-08-050PA-08-051 NIH SBIR/STTR Program Specifics

21 21 NIH SBIR/STTR Program Specifics

22 22 NIH SBIR/STTR Solicitation Research Topics Our Ideas* Biodefense Biosensors Nanotechnologies Bioinformatics Diagnostic and Therapeutic Devices Telehealth Biosilicon devices Biocompatible materials Acousto-optics / opto- electronics Imaging devices Genetically engineered proteins Proteomics / Genomics *Examples from 200+ pages of topics! Parent Solicitations SBIR: PA-08-050 and STTR: PA-08-051PA-08-050PA-08-051 NIH SBIR/STTR Program Specifics

23 23 Investigator-initiated Ideas Investigator-initiated Ideas (a.k.a. “I can’t find a topic match”) Research projects related to NIH mission “Other” areas of research within mission of an awarding component NIH SBIR/STTR Research Topics Keyword search the Solicitation Ctrl - F NIH SBIR/STTR Program Specifics

24 24 Small Business Concern Applicant Initiates Research Idea Grantee Conducts Research IC Staff Prepare funding Plan for IC Director NIH Center for Scientific Review Assign to IC and IRG Scientific Review Groups Evaluate Scientific Merit Advisory Council or Board Recommend approval IC Allocates Funds Submits SBIR/STTR Grant Application to NIH Electronically ~2-3 months after submission ~2-3 months after review NIH Review Process NIH SBIR/STTR Program Specifics

25 25 Phase IPhase IIPhase III Challenges for Biotech Firms: Navigating the Peaks and Valleys Unusually long development times (5-12 yrs) High & intense capital needs (>$1B) Exceptionally high burn rate for investment funds Multiple rounds of financing required Transitioning NIH SBIR/STTR Innovations to the Marketplace

26 26 NIH Technical Assistance Program: Understanding the “B” in SBIR A “menu” of technical assistance / training programs in: Strategic/business planning FDA requirements Technology valuation Manufacturing issues Patent and licensing issues Getting closer to the customer, the market, and the competition. Systematic approach to developing business strategies. Individualized assistance/mentoring/consulting. Menu:  Commercialization Assistance Program  Technology Niche Analysis Program  Manufacturing Assistance Program Transitioning NIH SBIR/STTR Innovations to the Marketplace

27 27 Technical Assistance Programs Commercialization Assistance Business & strategic planning Help help build strategic alliances and investor partnerships (Phase II awardees) Niche Assessment Identify other uses of technology Determines competitive advantages Develops market entry strategy (Phase I awardees) Manufacturing Assistance (Phase II awardees) Partnership with NIST MEP Centers Help make better manufacturing and operational decisions Transitioning NIH SBIR/STTR Innovations to the Marketplace

28 28 To (the) Market We Go NIH Pipeline to Partnerships (P2P) Technology Showcase Potential partners search for technologies of interest Facilitates matchmaking between NIH SBIR/STTR awardees and potential strategic partners and investors (Ph I and Ph II awardees) Transitioning NIH SBIR/STTR Innovations to the Marketplace

29 29 NIH Pipeline to Partnerships (P2P)

30 30 Pipeline to Partnerships (P2P) Potential partner identifies technology of interest and contacts company's Web site. Transitioning NIH SBIR/STTR Innovations to the Marketplace

31 31 Pipeline to Partnerships (P2P) Transitioning NIH SBIR/STTR Innovations to the Marketplace

32 32 Phase III Commercialization An evaluation of NIH Ph II SBIR awardees (FY1992-2001) and regular updates document the continued achievements of SBIR awardees over time. Number of awardees with FDA-approved projects increased 51%, from 59 in 2002 to 89 in March 2007. Estimated cumulative sales to date increased over 200%, from $821 million to $1.95 billion in March 2007. Number of awardees receiving additional non-SBIR funding or capital increased 33%, from 281 in 2002 to 375 in March 2007. A recent second evaluation of NIH Ph II SBIR awardees (FY2002-2006) show $395M for another 189 awardees.

33 33 Top 10 Reasons

34 34 Top 10 Reasons 10. 10. Over $2.3 Billion available- annually 9.NOT A LOAN 9. NOT A LOAN - no repayment 8. 8. Provides recognition, verification and visibility 7. 7. Potential leveraging tool to attract venture capital/other sources of $$$

35 35 5. 5. Creates jobs / stimulates local and state economies – stronger National Economy 4. 4. Provides seed money to fund high risk projects 6.niversities, large 6. Foster partnerships (universities, large corporations) that of corporations) that enhance competitiveness of small businesses in marketplace small businesses in marketplace Top 10 Reasons

36 36 3. 3. Intellectual property rights are normally retained by the small business 2. 2. Small business concerns are recognized as a unique national resource of technological innovation – creating AND sustaining Top 10 Reasons

37 37 BrainGate TM System Cyberkinetics Neurotechnology Systems, Inc. Percutaneous Ventricular Assist Device TM Cardiac Assist, Inc. Next Generation Therapeutics TM GlycoFi, Inc. Intralase Corporation Femtosecond Laser Intralase Corporation PediSedate TM Design Continuum, Inc. 1. Opportunity to make important contributions to America the health of America Top 10 Reasons

38 38 Summary

39 39 Summary: Importance of NIH SBIR/STTR Funding Funds early-stage, high-risk projects for which private and public funds are not traditionally available –Establish feasibility of ideas with commercial potential –Verify technology and leverage SBIR funds to attract other funding Plays an important role is achieving NIH mission of improving human health –Develop tangible products and services resulting from innovative R&D approaches to improving health Focuses on commercialization of the outcomes of research – a unique feature. –SBIR program supplements -- but does not supplant or diminish -- the traditional research programs of NIH. Summary

40 40 NIH SBIR/STTR Program Key Features SBIR and STTR Program  Single SBIR/STTR grant solicitation  Investigator-initiated research ideas  Supplemental Funding Opportunities (NIH Guide for Grants and Contracts)  Electronic Submission  Awards: Grants, Contracts, Cooperative Agreements Multiple Receipt Dates (Grants)  April 5, August 5, December 5  May 7, September 7, January 7 (AIDS)  Contracts: Early November Budget and Project Period  $100K/6 months (Ph I)  $750K/2 yrs (Ph II)  Deviations permitted where scientifically appropriate. External Peer Review  Option to request review group  Experts from Academia/Industry  5 Criteria: Significance, Approach, PI(s), Innovation, Environment  Summary Statement for all applicants  One resubmission (eff. Jan 2009) Gap Funding Programs  No-Cost Extensions (NCE)  Ph I/Ph II Fast Track  Administrative Supplements Technical Assistance Programs  Technology Niche Assessment  Commercialization Assistance  Pipeline to Partnerships (P2P) Summary

41 41 NIH SBIR/STTR Program Enhancements Project Director/Principal Investigator (PD/PI)  Multiple PD/PI allowed  Waivers for 51% employment requirement Performance of Work  Waivers for work outside U.S.  Deviations from SBIR subcontract percentages (not for STTR) Budget and Project Period  Deviations permitted  Reasonable and scientifically appropriate for success of the project. SBIR-STTR Conversions (vice-versa)  Phase I stage allowed Summary Phase II Competing Renewal  Up to $1M/year for 3 years  Additional R&D to meet FDA regulatory requirements OR  Complex instrumentation/clinical research tools/behavior interventions Program Evaluation Tool  Performance Outcomes Database System (PODS)  Regular updates  Accessible to NIH staff

42 OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR Jo Anne Goodnight NIH SBIR/STTR Program Coordinator Phone: 301-435-2688 Fax: 301-480-0146 Email: Kay Etzler SBIR/STTR Program Analyst Phone: 301-435-2713 Fax: 301-480-0146 Email: Thank You!

Download ppt "11 Jo Anne Goodnight SBIR/STTR Program Coordinator Office of Extramural Research, NIH 301.435.2688 “Lab to Life” NIH SBIR/STTR Funding Opportu“NIH”tieS."

Similar presentations

Ads by Google